Inhibition of human DNA topoisomerase I by new DNA minor groove ligands: derivatives of oligo-1,3-thiazolecarboxamides

A series of novel thiazole-containing oligopeptides (oligo-1,3-thiazolecarboxamides) interesting specifically with the minor groove of DNA was shown to inhibit human DNA topoisomerase I (topo I). Inhibitory effects of thiazole-containing oligopeptides (TCO) increase with the number of thiazole units...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Antisense & nucleic acid drug development 2001-06, Vol.11 (3), p.137-147
Hauptverfasser: Bugreev, D V, Vasyutina, E L, Ryabinin, V A, Sinyakov, A N, Buneva, V N, Nevinsky, G A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 147
container_issue 3
container_start_page 137
container_title Antisense & nucleic acid drug development
container_volume 11
creator Bugreev, D V
Vasyutina, E L
Ryabinin, V A
Sinyakov, A N
Buneva, V N
Nevinsky, G A
description A series of novel thiazole-containing oligopeptides (oligo-1,3-thiazolecarboxamides) interesting specifically with the minor groove of DNA was shown to inhibit human DNA topoisomerase I (topo I). Inhibitory effects of thiazole-containing oligopeptides (TCO) increase with the number of thiazole units in such compounds. Inhibitory properties of TCO containing 3 or 4 thiazole units were shown to be 3-10 times better than those of the well-known natural antibiotic, distamycin A containing pyrrole rings. The structure of various additional groups attached to the N-terminus and C-terminus of TCO had no significant effect on TCO interaction with the complex of DNA and topo I. TCO were shown to be capable of binding with double-stranded DNA (dsDNA), and the majority of TCO analyzed were more effective in binding with dsDNA than distamycin A. Possible reasons for the different effects of distamycin A and TCO on the reaction of relaxation catalyzed by topo I are discussed.
doi_str_mv 10.1089/108729001300338663
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70992903</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17928439</sourcerecordid><originalsourceid>FETCH-LOGICAL-c330t-685b2b3784322ffc029509e1316418043192bcce7d833a06a6048b4df294781c3</originalsourceid><addsrcrecordid>eNqFUTtPwzAQ9gCipfAHGJAnJgK2Lw-brSqvShUsMEd24rRGSVzsJFB-PS6txMDAcid9L53uQ-iMkitKuLgOI2OCEAqEAPA0hQM03oJRQNMROvb-LbCMJ3CERpTGcZpwMUbDvF0ZZTpjW2wrvOob2eLbpynu7NoabxvtpNd4jtUGt_rjh2pMax1eOmsHjWuzlG3pb3CpnRlkZwbtt0k2EDailxB1KyO_bK0L6ZT9lI0ptT9Bh5WsvT7d7wl6vb97mT1Gi-eH-Wy6iAoA0kUpTxRTkPEYGKuqgjCREKEp0DSmnMRABVNFobOSA0iSypTEXMVlxUSccVrABF3sctfOvvfad3ljfKHrWrba9j7PiBDhQfCvkGaChStEELKdsHDWe6erfO1MI90mpyTfVpH_rSKYzvfpvWp0-WvZ9wDfvbOEtA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17928439</pqid></control><display><type>article</type><title>Inhibition of human DNA topoisomerase I by new DNA minor groove ligands: derivatives of oligo-1,3-thiazolecarboxamides</title><source>Mary Ann Liebert Online Subscription</source><source>MEDLINE</source><creator>Bugreev, D V ; Vasyutina, E L ; Ryabinin, V A ; Sinyakov, A N ; Buneva, V N ; Nevinsky, G A</creator><creatorcontrib>Bugreev, D V ; Vasyutina, E L ; Ryabinin, V A ; Sinyakov, A N ; Buneva, V N ; Nevinsky, G A</creatorcontrib><description>A series of novel thiazole-containing oligopeptides (oligo-1,3-thiazolecarboxamides) interesting specifically with the minor groove of DNA was shown to inhibit human DNA topoisomerase I (topo I). Inhibitory effects of thiazole-containing oligopeptides (TCO) increase with the number of thiazole units in such compounds. Inhibitory properties of TCO containing 3 or 4 thiazole units were shown to be 3-10 times better than those of the well-known natural antibiotic, distamycin A containing pyrrole rings. The structure of various additional groups attached to the N-terminus and C-terminus of TCO had no significant effect on TCO interaction with the complex of DNA and topo I. TCO were shown to be capable of binding with double-stranded DNA (dsDNA), and the majority of TCO analyzed were more effective in binding with dsDNA than distamycin A. Possible reasons for the different effects of distamycin A and TCO on the reaction of relaxation catalyzed by topo I are discussed.</description><identifier>ISSN: 1087-2906</identifier><identifier>DOI: 10.1089/108729001300338663</identifier><identifier>PMID: 11446589</identifier><language>eng</language><publisher>United States</publisher><subject>Base Sequence ; Binding Sites ; distamycin A ; Distamycins - chemistry ; Distamycins - pharmacology ; DNA - chemistry ; DNA - drug effects ; Humans ; In Vitro Techniques ; Ligands ; Nucleic Acid Conformation ; Oligo-1,3-thiazolecarboxamide ; Oligo-1,3-thiazolecarboxamides ; Oligodeoxyribonucleotides - chemistry ; Oligopeptides - chemical synthesis ; Oligopeptides - chemistry ; Oligopeptides - pharmacology ; Thiazoles - chemical synthesis ; Thiazoles - chemistry ; Thiazoles - pharmacology ; Topoisomerase I Inhibitors</subject><ispartof>Antisense &amp; nucleic acid drug development, 2001-06, Vol.11 (3), p.137-147</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c330t-685b2b3784322ffc029509e1316418043192bcce7d833a06a6048b4df294781c3</citedby><cites>FETCH-LOGICAL-c330t-685b2b3784322ffc029509e1316418043192bcce7d833a06a6048b4df294781c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,3028,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11446589$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bugreev, D V</creatorcontrib><creatorcontrib>Vasyutina, E L</creatorcontrib><creatorcontrib>Ryabinin, V A</creatorcontrib><creatorcontrib>Sinyakov, A N</creatorcontrib><creatorcontrib>Buneva, V N</creatorcontrib><creatorcontrib>Nevinsky, G A</creatorcontrib><title>Inhibition of human DNA topoisomerase I by new DNA minor groove ligands: derivatives of oligo-1,3-thiazolecarboxamides</title><title>Antisense &amp; nucleic acid drug development</title><addtitle>Antisense Nucleic Acid Drug Dev</addtitle><description>A series of novel thiazole-containing oligopeptides (oligo-1,3-thiazolecarboxamides) interesting specifically with the minor groove of DNA was shown to inhibit human DNA topoisomerase I (topo I). Inhibitory effects of thiazole-containing oligopeptides (TCO) increase with the number of thiazole units in such compounds. Inhibitory properties of TCO containing 3 or 4 thiazole units were shown to be 3-10 times better than those of the well-known natural antibiotic, distamycin A containing pyrrole rings. The structure of various additional groups attached to the N-terminus and C-terminus of TCO had no significant effect on TCO interaction with the complex of DNA and topo I. TCO were shown to be capable of binding with double-stranded DNA (dsDNA), and the majority of TCO analyzed were more effective in binding with dsDNA than distamycin A. Possible reasons for the different effects of distamycin A and TCO on the reaction of relaxation catalyzed by topo I are discussed.</description><subject>Base Sequence</subject><subject>Binding Sites</subject><subject>distamycin A</subject><subject>Distamycins - chemistry</subject><subject>Distamycins - pharmacology</subject><subject>DNA - chemistry</subject><subject>DNA - drug effects</subject><subject>Humans</subject><subject>In Vitro Techniques</subject><subject>Ligands</subject><subject>Nucleic Acid Conformation</subject><subject>Oligo-1,3-thiazolecarboxamide</subject><subject>Oligo-1,3-thiazolecarboxamides</subject><subject>Oligodeoxyribonucleotides - chemistry</subject><subject>Oligopeptides - chemical synthesis</subject><subject>Oligopeptides - chemistry</subject><subject>Oligopeptides - pharmacology</subject><subject>Thiazoles - chemical synthesis</subject><subject>Thiazoles - chemistry</subject><subject>Thiazoles - pharmacology</subject><subject>Topoisomerase I Inhibitors</subject><issn>1087-2906</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFUTtPwzAQ9gCipfAHGJAnJgK2Lw-brSqvShUsMEd24rRGSVzsJFB-PS6txMDAcid9L53uQ-iMkitKuLgOI2OCEAqEAPA0hQM03oJRQNMROvb-LbCMJ3CERpTGcZpwMUbDvF0ZZTpjW2wrvOob2eLbpynu7NoabxvtpNd4jtUGt_rjh2pMax1eOmsHjWuzlG3pb3CpnRlkZwbtt0k2EDailxB1KyO_bK0L6ZT9lI0ptT9Bh5WsvT7d7wl6vb97mT1Gi-eH-Wy6iAoA0kUpTxRTkPEYGKuqgjCREKEp0DSmnMRABVNFobOSA0iSypTEXMVlxUSccVrABF3sctfOvvfad3ljfKHrWrba9j7PiBDhQfCvkGaChStEELKdsHDWe6erfO1MI90mpyTfVpH_rSKYzvfpvWp0-WvZ9wDfvbOEtA</recordid><startdate>20010601</startdate><enddate>20010601</enddate><creator>Bugreev, D V</creator><creator>Vasyutina, E L</creator><creator>Ryabinin, V A</creator><creator>Sinyakov, A N</creator><creator>Buneva, V N</creator><creator>Nevinsky, G A</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7TM</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20010601</creationdate><title>Inhibition of human DNA topoisomerase I by new DNA minor groove ligands: derivatives of oligo-1,3-thiazolecarboxamides</title><author>Bugreev, D V ; Vasyutina, E L ; Ryabinin, V A ; Sinyakov, A N ; Buneva, V N ; Nevinsky, G A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c330t-685b2b3784322ffc029509e1316418043192bcce7d833a06a6048b4df294781c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Base Sequence</topic><topic>Binding Sites</topic><topic>distamycin A</topic><topic>Distamycins - chemistry</topic><topic>Distamycins - pharmacology</topic><topic>DNA - chemistry</topic><topic>DNA - drug effects</topic><topic>Humans</topic><topic>In Vitro Techniques</topic><topic>Ligands</topic><topic>Nucleic Acid Conformation</topic><topic>Oligo-1,3-thiazolecarboxamide</topic><topic>Oligo-1,3-thiazolecarboxamides</topic><topic>Oligodeoxyribonucleotides - chemistry</topic><topic>Oligopeptides - chemical synthesis</topic><topic>Oligopeptides - chemistry</topic><topic>Oligopeptides - pharmacology</topic><topic>Thiazoles - chemical synthesis</topic><topic>Thiazoles - chemistry</topic><topic>Thiazoles - pharmacology</topic><topic>Topoisomerase I Inhibitors</topic><toplevel>online_resources</toplevel><creatorcontrib>Bugreev, D V</creatorcontrib><creatorcontrib>Vasyutina, E L</creatorcontrib><creatorcontrib>Ryabinin, V A</creatorcontrib><creatorcontrib>Sinyakov, A N</creatorcontrib><creatorcontrib>Buneva, V N</creatorcontrib><creatorcontrib>Nevinsky, G A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Antisense &amp; nucleic acid drug development</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bugreev, D V</au><au>Vasyutina, E L</au><au>Ryabinin, V A</au><au>Sinyakov, A N</au><au>Buneva, V N</au><au>Nevinsky, G A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Inhibition of human DNA topoisomerase I by new DNA minor groove ligands: derivatives of oligo-1,3-thiazolecarboxamides</atitle><jtitle>Antisense &amp; nucleic acid drug development</jtitle><addtitle>Antisense Nucleic Acid Drug Dev</addtitle><date>2001-06-01</date><risdate>2001</risdate><volume>11</volume><issue>3</issue><spage>137</spage><epage>147</epage><pages>137-147</pages><issn>1087-2906</issn><abstract>A series of novel thiazole-containing oligopeptides (oligo-1,3-thiazolecarboxamides) interesting specifically with the minor groove of DNA was shown to inhibit human DNA topoisomerase I (topo I). Inhibitory effects of thiazole-containing oligopeptides (TCO) increase with the number of thiazole units in such compounds. Inhibitory properties of TCO containing 3 or 4 thiazole units were shown to be 3-10 times better than those of the well-known natural antibiotic, distamycin A containing pyrrole rings. The structure of various additional groups attached to the N-terminus and C-terminus of TCO had no significant effect on TCO interaction with the complex of DNA and topo I. TCO were shown to be capable of binding with double-stranded DNA (dsDNA), and the majority of TCO analyzed were more effective in binding with dsDNA than distamycin A. Possible reasons for the different effects of distamycin A and TCO on the reaction of relaxation catalyzed by topo I are discussed.</abstract><cop>United States</cop><pmid>11446589</pmid><doi>10.1089/108729001300338663</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1087-2906
ispartof Antisense & nucleic acid drug development, 2001-06, Vol.11 (3), p.137-147
issn 1087-2906
language eng
recordid cdi_proquest_miscellaneous_70992903
source Mary Ann Liebert Online Subscription; MEDLINE
subjects Base Sequence
Binding Sites
distamycin A
Distamycins - chemistry
Distamycins - pharmacology
DNA - chemistry
DNA - drug effects
Humans
In Vitro Techniques
Ligands
Nucleic Acid Conformation
Oligo-1,3-thiazolecarboxamide
Oligo-1,3-thiazolecarboxamides
Oligodeoxyribonucleotides - chemistry
Oligopeptides - chemical synthesis
Oligopeptides - chemistry
Oligopeptides - pharmacology
Thiazoles - chemical synthesis
Thiazoles - chemistry
Thiazoles - pharmacology
Topoisomerase I Inhibitors
title Inhibition of human DNA topoisomerase I by new DNA minor groove ligands: derivatives of oligo-1,3-thiazolecarboxamides
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T15%3A03%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Inhibition%20of%20human%20DNA%20topoisomerase%20I%20by%20new%20DNA%20minor%20groove%20ligands:%20derivatives%20of%20oligo-1,3-thiazolecarboxamides&rft.jtitle=Antisense%20&%20nucleic%20acid%20drug%20development&rft.au=Bugreev,%20D%20V&rft.date=2001-06-01&rft.volume=11&rft.issue=3&rft.spage=137&rft.epage=147&rft.pages=137-147&rft.issn=1087-2906&rft_id=info:doi/10.1089/108729001300338663&rft_dat=%3Cproquest_cross%3E17928439%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17928439&rft_id=info:pmid/11446589&rfr_iscdi=true